Axel Nierhaus

Shares of Cytosorbents Corp (NASDAQ: CTSO) gained more than 10 percent on Friday after the company presented data from its first CytoSorb investigator-initiated septic shock study at an industry conference in Germany. According to the company's press release, "All patients had...